CaliPharms Inc (KGET)

[cybear_mn]

PART IV — OTHER INFORMATION



(1)


Name and telephone number of person to contact in regard to this notification






Bo Linton


(727)


330-3774




(Name)


(Area Code)


(Telephone Number)



(2)


Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ¨ No x

10-K 12/31/2014


(3)


Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨ No x



If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.